The risk of hepatitis B virus (HBV) reactivation in patients with gastrointestinal stromal tumours (GIST) under imatinib mesylate treatment

被引:0
|
作者
Soufleris, K. [1 ]
Lazaraki, G. [1 ]
Pavlioglou, P. [1 ]
Stergiou, E. [1 ]
Paraskevaidou, K. [1 ]
Tzilves, D. [1 ]
机构
[1] Thessaloniki Canc Hosp Theagenio, Thessaloniki, Greece
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P - 347
引用
收藏
页码:96 / 96
页数:1
相关论文
共 50 条
  • [1] Imatinib mesylate in the management of gastrointestinal stromal tumours (GIST)
    Kurteva G.P.
    Kurtev P.F.
    memo - Magazine of European Medical Oncology, 2010, 3 (2) : 49 - 52
  • [2] Imatinib mesylate - In the treatment of gastrointestinal stromal tumours
    Croom, KF
    Perry, CM
    DRUGS, 2003, 63 (05) : 513 - 522
  • [3] Hepatitis B Virus Reactivation in Gastrointestinal Stromal Tumor Patients Treated With Imatinib
    Lei, Tianxiang
    Tan, Fengbo
    Hou, Zhouhua
    Liu, Peng
    Zhao, Xianhui
    Liu, Heli
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [4] Imatinib mesylate in treatment of advanced gastrointestinal stromal tumours
    Petricevic, B
    Vrbanec, D
    Belev, B
    Plestina, S
    Herceg, D
    Dedic-Plavetic, N
    ANNALS OF ONCOLOGY, 2005, 16 : 313 - 313
  • [5] Imatinib mesylate induced fatal hepatitis B virus (HBV) reactivation in a patient with CML.
    Kai, T
    Ikeda, K
    Shiga, Y
    Kimura, H
    Noji, H
    Ogawa, K
    Takeyama, K
    Maruyama, Y
    BLOOD, 2004, 104 (11) : 253B - 253B
  • [6] Genetic changes in advanced gastrointestinal stromal tumor (GIST) patients during imatinib mesylate treatment
    Yeh, Chun-Nan
    Chen, Tsung-Wen
    Liu, Feng-Yuan
    Jan, Yi-Yin
    Chen, Miin-Fu
    LANGENBECKS ARCHIVES OF SURGERY, 2006, 391 (06) : 615 - 621
  • [7] Necrotizing granulomatous disease in patients receiving imatinib mesylate treatment for gastrointestinal stromal tumors (GIST)
    Brueckl, V
    Agaimy, A.
    Ullrich, E.
    Krieg, S.
    Stegmann, A.
    Mackensen, A.
    Meidenbauer, N.
    ONKOLOGIE, 2011, 34 : 252 - 252
  • [8] Surgical Management in Metastatic Gastrointestinal Stromal Tumor (GIST) Patients After Imatinib Mesylate Treatment
    Yeh, Chun-Nan
    Chen, Tsung-Wen
    Tseng, Jeng-Hwei
    Liu, Yu-Yin
    Wang, Shang-Yu
    Tsai, Chun-Yi
    Chiang, Kun-Chun
    Hwang, Tsann-Long
    Jan, Yi-Yin
    Chen, Miin-Fu
    JOURNAL OF SURGICAL ONCOLOGY, 2010, 102 (06) : 599 - 603
  • [9] Necrotizing granulomatous disease in patients receiving imatinib mesylate treatment for gastrointestinal stromal tumors (GIST)
    Meidenbauer, N.
    Stegmann, A.
    Mackensen, A.
    Agaimy, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] Genetic changes in advanced gastrointestinal stromal tumor (GIST) patients during imatinib mesylate treatment
    Chun-Nan Yeh
    Tsung-Wen Chen
    Feng-Yuan Liu
    Yi-Yin Jan
    Miin-Fu Chen
    Langenbeck's Archives of Surgery, 2006, 391 : 615 - 621